Las Vegas, Nevada (PRWEB) March 12, 2014
The top Las Vegas pain management centers, Nevada Pain, are now offering regenerative medicine treatments including stem cell therapy and platelet rich plasma therapy. These treatments offer significant potential for repairing injured soft tissues and arthritis. Call (702) 323-0553 for more information and scheduling.
Traditional pain management treatments typically work exceptionally well, however, they act as a proverbial "band aid" to mask pain. Regenerative medicine, on the other hand, may regenerate damaged tissue while providing exceptional pain relief.
Treatments are offered by the Board Certified, Award Winning Las Vegas pain management doctors at Nevada Pain. Platelet rich plasma therapy is one of the treatments offered, which involves a simple blood draw from the patient. The blood is spun rapidly to create a mixture of concentrated platelets and growth factors, which is then injected into the problem area.
Stem cell injections involve treatments with either bone marrow, fat derived or amniotic derived material. The injections are offered as an outpatient and involve very little risk. Each treatment provides a significant concentration of growth factors and stem cells to help with repair.
In addition to regenerative medicine options, Nevada Pain offers over 50 pain management treatments including radiofrequency ablation, spinal cord stimulator implants, several types of epidural injections, and all kinds of nerve blocks. Success rates at the clinic typically exceed 90%.
For more information and scheduling, call (702) 323-0553.
- USC biological imaging innovator elected to National Academy of Medicine > News > USC Dornsife - USC Dornsife College of Letters, Arts and... - October 24th, 2020
- Repurposing and Combining Drugs An Effective Cancer Treatment Strategy - Technology Networks - October 24th, 2020
- Rates of Invasive Pulmonary Aspergillosis in ICU Patients With Influenza Far Lower Than Previously Thought - Contagionlive.com - October 24th, 2020
- Stem Cell and Regenerative Therapy Market Report to Describe Major Companies and Their Strategies (2019-2024) - PRnews Leader - October 23rd, 2020
- Baby Gets Early Stem Cell Transplant to Treat Rare Disease Thanks to Newborn Screening - University of Michigan Health System News - October 23rd, 2020
- Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn - GlobeNewswire - October 23rd, 2020
- Orchard Therapeutics CEO Bobby Gaspar, M.D., Ph.D., Appointed to the Alliance for Regenerative Medicine's 2021 Board of Directors - GlobeNewswire - October 23rd, 2020
- Be Biopharma debuts with $52M to advance engineered B-cell therapies - FierceBiotech - October 23rd, 2020
- Five Penn faculty elected to the National Academy of Medicine - Penn Today - October 21st, 2020
- Vor Biopharma Appoints Matthew R. Patterson to its Board of Directors - BioSpace - October 21st, 2020
- Harvard Business School and Harvard's Department of Stem Cell and Regenerative Biology Receive $25 Million Gift from Chris and Carrie Shumway to... - October 20th, 2020
- Human Embryonic Stem Cells (HESC) Industry Research Report, Growth Trends and Competitive Analysis 2020-2027: ESI BIO, Thermo Fisher, BioTime,... - October 20th, 2020
- Notch Therapeutics Strengthens Leadership Team with Appointment of Kamran Alam as CFO and Gregory Block as SVP, Corporate Development - PRNewswire - October 20th, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 Potential Growth, Competitive Landscape and Development of Industry by 2025 Wall Street... - October 20th, 2020
- Regenerative Medicine Market 2020 Industry Insights by Share, Emerging Trends, Regional Analysis, Segments, Prime Players, Drivers, Growth Factor and... - October 20th, 2020
- The untapped market of cord blood banking - The Malaysian Reserve - October 15th, 2020
- Singapore invents digitized optimization of culture conditions for cell therapy - BSA bureau - October 15th, 2020
- Pluristem Announces Clearance to Move Forward with Enrollment for Cohort II in an Investigator-Led Phase I/II Chronic Graft vs Host Disease... - October 15th, 2020
- U of T's Medicine by Design invests $1 million to advance new ideas in regenerative medicine - News@UofT - October 10th, 2020
- Proposition 14 would authorize state to borrow $5.5 billon for stem cell research - KESQ - October 10th, 2020
- AIVITA Biomedical's Stem Cell Therapeutic in Vision Loss Published in Investigative Ophthalmology & Vision Science - PRNewswire - October 10th, 2020
- Regenerative Medicine Market | Increasing Prevalence of Chronic Diseases to Boost the Market Growth | Technavio - Business Wire - October 10th, 2020
- University of Wisconsin Researchers Use Stem Cells to Treat Parkinson's - Gilmore Health News - October 10th, 2020
- Cartilage Repair/ Cartilage Regeneration Market worth $1,603 million by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire - October 10th, 2020
- Mission: a cure to cancer - Innovation Origins - October 10th, 2020
- What You Need to Know About Prop 14, The Stem Cell Research Bond (Transcript) - KQED - October 3rd, 2020
- SMART researchers receive Intra-CREATE grant for personalized medicine and cell therapy - MIT News - October 3rd, 2020
- Abu Dhabi Stem Cells Centre collaborating with Israeli firm for COVID-19 therapies - Gulf News - October 3rd, 2020
- Majority of Respondents Support Chimeric Animal Research: Survey - The Scientist - October 3rd, 2020
- Hair Regeneration Therapy Company Stemson Therapeutics Raises $7.5 Million - Pulse 2.0 - September 21st, 2020
- Election 2020: Prop. 14 and stem cell research funding - KCBX - September 21st, 2020
- Intestinal Organoid Built That Looks and Functions Like Real Tissue - Genetic Engineering & Biotechnology News - September 21st, 2020
- Recruiting Faculty in Molecular and Cellular Biology - Nature.com - September 19th, 2020
- Regenerative Therapy by Dr. Roshni Patel on Better CT - Farmington, CT - Patch.com - September 19th, 2020
- California's $7.8 Billion Proposition 14 Could Expand Conflicts of Interest in Stem Cell Research | K. Lloyd Billingsley - The Beacon - September 15th, 2020
- GA sues therapists after making $6.4 Million on unproven products - ValdostaToday.com - September 15th, 2020
- NK Cell Therapy and Stem Cell Therapy Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to... - September 15th, 2020
- LifeGaines Medical and Aesthetics Center in Boca Raton Helps Patients Stay Young and Healthy - Yahoo Finance - September 15th, 2020
- New research connects the hormones we're born with to lifetime risk for immunological diseases - MSUToday - September 15th, 2020
- The Tax Watchers: How would you spend other people's money? - Fairfield Daily Republic - September 11th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Kewaskum Statesman News Journal - September 11th, 2020
- Plinabulin Granted FDA Breakthrough Therapy Designation for Chemotherapy-Induced Neutropenia - Targeted Oncology - September 11th, 2020
- GSK and J&J; alum Vijay Reddy to take control of R&D; at Tmunity; Andrew Hirsch exits Agios for CEO job at C4 Therapeutics - Endpoints News - September 11th, 2020
- New Data Further Reinforce Genentech's Ocrevus (ocrelizumab) as a Highly Effective Treatment for People With Multiple Sclerosis - BioSpace - September 11th, 2020
- Stem Cells Market Report, History and Forecast 2020-2027, Data Breakdown by Manufacturers, Key Regions, Types and Application - News Degree - September 11th, 2020
- Global Organoids and Spheroids Market Is Expected to Reach USD 2794.79 Million by 2027 : Fior Markets - GlobeNewswire - September 8th, 2020
- School of Science grows by 10 - MIT News - September 8th, 2020
- Faculty of Medicine researchers receive $2.8m for equipment and infrastructure - UBC Faculty of Medicine - UBC Faculty of Medicine - September 8th, 2020
- BeyondSpring Receives Breakthrough Therapy Designations from Both U.S. FDA and China NMPA for Plinabulin in Chemotherapy-Induced Neutropenia... - September 8th, 2020
- New HIV Gene Therapy, CAR-T Treatments Could be on the Horizon for Patients - BioSpace - September 4th, 2020
- Insights on the Global Animal Medicine Market to 2030 - Featuring Zoetis, Boehringer Ingelheim & Bayer Among Others - ResearchAndMarkets.com -... - September 4th, 2020
- Stem Cell And Regenerative Therapy Market Insights And Forecast 2019-2024 - Scientect - September 4th, 2020
- Magenta Therapeutics Appoints Lisa M. Olson as Chief Scientific Officer and Kevin B. Johnson as Senior Vice President, Head of Regulatory and Quality;... - September 4th, 2020
- Unraveling the use of CBD in veterinary medicine - Jill Lopez - September 4th, 2020
- BioForward Recognizes Scientific and Business Success with Annual Wisconsin Biohealth Awards - Business Wire - September 4th, 2020
- Biopreservation Market share forecast to witness considerable growth from 2020 to 2025 | By Top Leading Vendors , STEMCELL Technologies, WAK-Chemie... - September 4th, 2020
- An ancient virus might have made our hearts bigger - Scope - Scope - September 4th, 2020
- Worldwide Human Microbiome Immunology Therapeutics Industry to 2025 - The US Dominates the Global Market Landscape - PRNewswire - September 4th, 2020
- IFITM3 Forges Link Between Neuroinflammation and A Production - Alzforum - September 4th, 2020
- 3D Cell Culture Market 2020 by Application (Cancer Research, Stem Cell Research, Drug Discovery, Regererative Medicine), Top Countries Data with... - August 17th, 2020
- Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His Accomplishment in Human Genome Research - Financialbuzz.com - August 17th, 2020
- Every Sumatran rhino has died in Malaysia. Scientists want to bring them back with cloning technology - CNN - August 15th, 2020
- Brain Tumor Therapeutics Market 2020 Overview by Market Size, Share, Growth Rate, Products and Recent Developments, Forecast till 2023 - The Daily... - August 15th, 2020
- Cellect Biotechnology Ltd ADR (NASDAQ:APOP) Receives an Approval of a Pivotal Patent for Stem Cells Activation from the European Patent Office - BP... - August 15th, 2020
- Crispr Therapeutics: My #1 High-Risk Investment Idea - Seeking Alpha - August 15th, 2020
- Cell Expansion Market Research Report by Product, by Cell Type, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19... - August 13th, 2020
- NYC Healthcare Heroes Successfully Delivers More Than 400000 Care Packages with More Than 15 Million Products to 100 Hospitals and Healthcare... - August 13th, 2020
- Kerala Crash: A pregnant woman missed the flight because she didn't have a fit-to-fly certificate. But what is it and why do you need one? - Gulf News - August 13th, 2020
- Science News Roundup: Stem cells give hope for revival of Malaysia's extinct rhinos; Human versus disease showcased and more - Devdiscourse - August 13th, 2020
- Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue... - August 12th, 2020
- California Propositions on the 2020 Ballot - Fullerton Observer - August 12th, 2020
- Gore partners with San Diego company on cell delivery system with potential to treat Type 1 diabetes - delawarebusinessnow.com - August 12th, 2020
- FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting Laboratory Studies Suggest PneumoBlast COVID-19 Cell Therapy Reduces... - August 12th, 2020
- The Proteus Effect: Stem Cells and Their Promise for Medicine - August 10th, 2020
- Marker Therapeutics Reports Second Quarter 2020 Operating and Financial Results - PRNewswire - August 10th, 2020
- New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 - PharmiWeb.com - August 10th, 2020
- Regenerative Medicine & Stem Cell Practice in Medical Spas ... - August 10th, 2020
- Global Stem Cell Therapy Market Research Analysis Including Growth Factors, Types And Application By Regions From 2020 To 2024 - Owned - August 9th, 2020
- Dad with incurable cancer takes on 300 mile cycle challenge ahead of stem cell transplant - HeraldScotland - August 9th, 2020
- Potential Impact of COVID-19 Pandemic on Global Stem Cell Assay Coronavirus Impact Editon of Key Companies Merck, Thermo Fisher Scientific, GE... - August 8th, 2020
